Verastem (VSTM) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Verastem (VSTM) is Neutral.

The composite score behind that read is +0.03, weighing +0.28 of bullish evidence against -0.26 bearish.

Verastem last closed at $8.38, +3.33% on the session.

Against the IVW growth benchmark the position is +2.53% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for VSTM so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Verastem in the 2nd percentile on return on equity, where 100 is best.

Verastem is classified under Health Care / Biotechnology, with a market capitalisation of $734.47M.

StockMap tracks Verastem as the 151st largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Verastem ranks 83rd of 381 in the group, against a group median of -0.08.